Biological glycosidation of platenolide I (I), a biosynthetic intermediate of 16-membered macrolide antibiotic platenomycin aglycones, with desosamine by Streptomycetes producing 14-membered macrolide antibiotics was attempted.
malvinus MCRL 0388 was employed in the bioconversion study. Strain U 21 could not produce platenomycins, but was able to glycosidate I with mycaminose".
These organisms were maintained on a BENNET's agar slant at 27°C. Matured spores were inoculated into 500-ml Erlenmeyer flask containing 100 ml of a following seed medium; a medium for strains ISP 5016 and MCRL 0376: glucose 20 g and nutrient broth (Difco) 8.0 g per liter (tap water, pH unadjusted); a medium for strain U 21: glucose 20 g, peptone (Mikuni Kagaku Co., Ltd.) 10 g, beef extract (Mikuni Kagaku Co., Ltd.) 7.5 g, yeast extract (Oriental Kobo Co., Ltd.) 2.5 g and NaC1 3.0 g per liter (tap water, pH was adjusted to 6.5 before autoclaving). After inoculation, the strains were cultivated at 27°C for 40 hours on a rotatory shaker. The vegetative inoculums thus prepared were transformed to 100 ml of a production medium prepared in 500-m1 Erlenmeyer flasks (inoculum size : 1.0 -2.0 ml) and fermented at 27°C on a rotatory shaker (180 rpm). For fermentation of strains ISP 5016 and MCRL 0376, P-1 medium containing glucose 10 g, glycerol 10 g, Polypeptone (Kyokuto Seiyaku Co., Ltd.) 10 g, yeast extract (Oriental Kobo Co., Ltd.) 1.0 g, NaCl 5.0 g and CaC12 2.0 g per liter (tap water, pH unadjusted) was used, and an appropriate amount of I dissolved in ethyl alcohol was added after autoclaving. As the basal medium for the fermentation of strain U 21, P-2 medium was used which contained corn starch 15 g, glucose 5 g, soy bean meal 18 g, gluten feed (Nihon Shokuhin Co., Ltd.) 1.5 g, NaCI 5.0 g and CaCO3 2.0 g per liter (tap water, pH was adjusted to 7.0 before autoclaving.).
In the present experiments the antibiotic production was assayed by the cylinder cup-plate method using Bacillus subtilis PCI 219 as a test organism and picromycin as a reference standard. Antibiotic was expressed in terms of picromycin equivalent.
Detection of 5-0-desosaminyl-platenolide I (1II), 5-O-Desosaminyl-I4-hydroxy-platenolide I (IV) and 3-O-Propionyl-5-O-desosaminyl-9-dehydro-l8-oxo-platenolide I (V) The harvested broth of strains ISP 5016, MCRL 0376 or U 21 with platenolide I was centrifuged and the supernatant was extracted with ethyl acetate at pH 8.5. The extract was concentrated in vacuo, and oily residue was chromatographed on a silica gel plate with the solvent system consisted of CHC13 -MeOH -AcOH -H20 (79: 11: 8 : 2) and detected by spraying with 40% H2SO8 followed by heating. Rf values of the accumulants were 0.41 (coloration blue) for III , 0.32 (orange) for IV, 0.35 (brownish blue) for V, 0.53 (brown) for narbomycin and 0.48 (gray) for picromycin. III and IV produced in the fermentation beer were measured by the reflective UV spectrophotometer (Hitachi MPF-2A) which was capable to estimate directly the UV absorption of developed compounds on the thin-layer chromatogram.
As a standard substance for the quantitative determination, 9-dehydroleucomycin A8 was employed which showed the UV maximum at 280 nm similar to III and IV. As the Rf values of III, IV and 9-dehydroleucomycin A8 were fairly close to each other , the estimation of each compound was carried out by the methods reported in the previous paper').
Isolation and Purification of 5-O-Desosaminyl-platenolide I (III) and 5-O-Desosa _min_yl-14-hydroxy-platenolide I (IV)
The fermentation beer (9.3 liters) of strain MCRL 0376 cultivated about 80 hours in the medium containing I (100 mcg/ml) was filtered over Celite 545, and the filtrate was extracted with ethyl acetate (5.0 liters, twice) at pH 8.5. After concentration of the extract, bio-transformed products in ethyl acetate were transferred into diluted hydrochloric acid of pH 4.0. The acidic solution was re-extracted at pH 8.5 with benzene. The benzene layer was concentrated. A crude powder (4.7 g) thus obtained was then dissolved in ethyl acetate and chromatographed on the silica gel column using a solvent system of CHCI3 -ethyl acetate (9 : 1). The fractions of III and IV monitored by thin-layer chromatography were concentrated respectively, and III and IV were obtained as a crude powder. Further purification by alumina column chromatography using benzene -ethyl acetate (9: 1) gave III (112 mg) and IV (86 mg) as a homogeneous substance. These compounds were further recrystallized from benzene -n-hexane as colorless needles (III: 62 mg, IV: 37 mg), respectively.
Conversion of 5-0-Desosaminyl-platenolide I (111) to 5-O-Desosaminyl-14-hydroxy-platenolide I (IV)
After grown for 20 hours at 27°C in the fermentation medium described above, the cells of Isolation and Purification of 3-O-Propionyl-5-O-desosaminyl-9-dihydro-l8-oxo-platenolide I (V) The fermentation beer (9.1 liters) of strain U 21 harvested about 80 hours in a medium added with III (200 mcg/mI) was filtered over Celite 545, and the filtrate was treated as described above. Thus, the crude V was recovered. V was then purified by silica gel column chromatography with CHCI3 -ethyl acetate (9 : 1) followed by alumina column chromatography with benzene -ethyl alcohol (9 :1). Thus, V was obtained as a thin-layer chromatographically homogeneous powder. Recrystallization from benzene -n-hexane gave V as colorless needles (320 mg). The effects of platenolide 1 (1) on the production of narbomycin and picromycin by strains ISP 5016 and MCRL 0376 were first examined. Figs. 1-A and 1-B show the results. When I was added to the fermentation medium, the antibiotic production was depressed, the depression being more marked as the concentrations of I became higher. At the levels of 100 mcg/ml of I, only 26 mcg/ml (strain ISP 5016) and 15 mcg/ml (strain MCRL 0376) of the antibiotic production were observed. These productivities were respectively corresponded to about 28% and 30% of the fermentation without I. From previous experience3) the depression of the antibiotic production was suggested due to the accumulation of I-related compounds, so that the ethyl acetate extract of the broth was examined by silica gel thin-layer chromatography.
The thin-layer chromatography examined on the sample collected at various cultivation times indicated the production of one or two accumulants. Strain ISP 5016 produced III and strain MCRL 0376 gave III and IV. These compounds could be distinguished from narbomycin and picromycin by Rf values and colorations. When the thin-layer chromatogram was monitored at 280 nm before coloration by thin-layer reflective UV spectrophotometer, these compounds were able to be detected as the independent chromato-profiles.
Judging from the finding that III and IV gave the UV absorption maximum at 280 nm similar to I and showed the Rf values lower than I, these compounds were speculated as the new products derived from I and with more hydrophilic properties. In fact, III and IV were elucidated as 5-0-desosaminyl-platenolide I and 5-0- The maximum production of III was attained at 40 hours cultivation in both strains, when the antibiotic production reached to maximum as well. The accumulation of IV was observed only at the later stage of strain MCRL 0376 fermentation and attained to maximum after 100 hours.
Judging from these findings together with the structure elucidated, it was easily assumed that III and IV were in a precursor (III)-product (IV) relationship. To verify the relative relationships, the conversion experiments were attempted by fermentation and also by washed cell suspension technique using strain MCRL 0376. These results apparently show that IV was converted from III by a picromycin-producing strain, but not by an organism lacking picromycin-producing ability. Similar phenomenon was already resulted in the hydroxylation of narbomycin."
The authors found that III was easily hydroxylated by strain MCRL 0376. However, direct hydroxylation of platenomycins, demycarosyl platenomycins or leucomycins by this organism was not achieved. Therefore, a methyl function at C-18 position (Cis-CHs) in an aglycone may be a necessary factor in the hydroxylation of 16-membered macrolide antibiotic aglycones by this strain. Fig. 2 . The course of III and IV production by Streptomyces narbonensis ISP 5016 and Streptomyces venezuelae MCRL 0376 in the medium containing I. Strain ISP 5016 and MCRL 0376 were cultured in the P-1 medium containing 1 (100 mcg/ml). The amounts of III and IV accumulated were estimated by thin-layer chromatography using reflective spectrophotometer. OMURA et al.') and RAKHIT et a1.9' reported that the Cig-CHO function in the macrolide aglycone was essential for the antibiotic activity. As the compounds possessing a C18-CH313' or Cis-CH2OHs,1o) function show almost no or very low antibiotic activity, and on that point of view, the biological conversion of III or IV to a C18-CHO compound was considered.
As reported previously,') 5-0-mycaminosyl-platenolide I (Cis-CH3) was easily converted to demycarosyl platenomycin (Cis-CHO) by a platenomycin-producing strain MCRL 0388 or its blocked mutant U 21, so the oxidation of C18-CHs of III was attempted by these strains. When cultured in the medium containing III, the mutant U 21 could convert III completely after 80 hours.
Continuation of fermentation decreased the amount of the product.
The converted products were isolated and their structures were examined. More than five bioconverted products were detected in the fermentation broth, when the ethyl acetate extract of the broth was examined by thin-layer chromatography. Among the products, V elucidated as 3-0-propionyl-5-O-desosaminyl-9-dihydro-18-oxo-platenolide I was dominant. The structure elucidation of minor products were not accomplished, however, the IR, UV and mass spectral analysis showed these compounds were 3-hydroxyl, 3-0-acetyl and/or 9-dihydro derivatives of 16-membered macrolide antibiotic which were similar to platenomycins, but all products contained desosamine in place of mycarosyl-mycaminose. The accumulation of these compounds could easily be speculated by recalling the results of the biogenetic studies of platenomycins.
The biological conversion of IV was also attempted similarly. However, the converted products were not detected in the fermentation beer. The physicochemical properties of III, IV and V were listed in Table 1 . These compounds were soluble in ethyl alcohol, methyl alcohol, ethyl acetate, chloroform and benzene, but hardly soluble in petroleum ether, n-hexane and water. They gave negative erythromycin, ferric chloride Besides a molecular ion (M-'-) at m/e 525, a characteristic fragment peak at m/e 351 was found, which was analysed as m/e 351.2160 (C2oHs1O3, 4= -0.9 mmu) by high resolution mass spectrometry.
From the NMR spectrum (Fig. 4-A (367.2128, CsoH31O6, 4=0.9 mmu) may be comparable to that of III at m/e 351. These peaks were derived from an aglycone part. Shifting of the peak at m/e 367 of IV to nr/e 451 by acetylation showed the presence of two acetylable units in an aglycone of IV. Therefore, an aglycone of IV was to a quartet (H-15) and the simplified olefinic proton (H-13) signal, respectively. This showed that H-15 and H-13 signals were coupling with a multiplet (H-14) at 63.96. Thus, one additional hydroxyl function was assigned to be present at the C-14 position and the structure of IV was concluded to be a 14-oxy derivative of III. The antibiotic activities were determined by an agar dilution method. The results are listed in 
